• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/60

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

60 Cards in this Set

  • Front
  • Back

2 types of breast carcinoma in situ?

Lobar (LCIS)


Ductal (DCIS)

Where does the carcinoma in situ arise?

Terminal ductal lobular unit (TDLU)

Histological feature of LCIS

- maintains TDLU architecture


- fills and expands acini


- small, monomorphic cells


- bland, discohesive cells


- no calcification or necrosis





Histological features of DCIS

- distant or unfolds TDLU


- look like a duct(s)


- COMEDO: pleomorphic/ high grade, central necrosis


- NON COMEDO: calcified, cribiform (cookie cutter shape), solid

Benign disorders of growth in BC

-fibrocystic disease


- sclerosing adenosis



benign neoplasia of BC

- fibroadenoma

malignant neoplasia

-DCIS


- LCIS


- Invasive Lobular


- Invasive Ductal (NOS/NTS)

What is a cyst?

- epithelial lined sac containing proteinaceous fluid


- distinctly eosinophilic cytoplasm (apocrine metaplasia)

what is a blue domed cyst?

large cysts which may appear blue/brown due to turbid fluid

whats is fibrosis?

increased fibrous tissue (collagen)


- may cause chronic inflammation and scarring due to cyst leakage


- may result in sclerosis (hardening)

what is adenosis?

increased no. of acini per lobule



what are the constituents of fibrocystic change?

fibrosis - increased stromal fibrous tissue


cysts formation- dilatation of ducts, unfolding lobules


apocrine metaplasia

fibrocystic change in the breast is:

-lumpy, bumpy breasts +- mastalgia


- very common


- hormone responsive

2 kinds of fibrocystic change:

1. Simple: no epithelial hyperplasia (no increased cancer risk)




2. Proliferative: epithelial hyperplasia


- lumen filled with heterogenous luminal and myoepithelial cells


- irregular, slit-like fenestrations


- cancer risk increases with increase proliferation

4 classes of fibrocystic change

- mild


- moderate


- severe


- atypical

what does fibrocystic change look like on a mammogram?

microcalcifications

what is sclerosing adenosis?

Intralobular fibrosis


- may compress acini in centre, usually dilated at periphery


- may mimic cancer-stromal fibrosis completely compress lumens - solid cords of cells

What in the breast can sometimes be misdiagnosed for breast cancer?

sclerosing adenosis

what is a fibroadenoma?

-benign neoplasm of interlobular fibroblasts (monoclonal fibroblastic stroma)


- hyperplasia/ proliferation of ducts = adenosis

what does a fibroadenoma look like?

-well circumscribed


- rubbery-rapid growth compresses surrounding tissue


- freely mobile "breast mice"

fibroadenomas are:

- hormone responsive


- most common benign breast tumour in 20-30yo

breast cancer epidemiology

- most commonly diagnosed cancer in Aust women (exc non-melanoma skin ca)




- 2nd most common of cancer related death in women

breast cancer risk factors:

- age


-age at menarche


- age at first live birth


- first degree relatives with breast cancer


- atypical hyperplasia


- race/ethnicity (non-hispanic white @highest risk)


- oestrogen exposure


- breast density


- radiation exposure


- obesity


-breast feeding (protective)


- geography / location

Breast Carcinogenesis:

Where is DCIS usually located?

one quadrant


one breast

Where is LCIS usually located?

multifocal


bilateral (20-40%)

Is e-cadherin present in IHC for LCIS?

no

Is e-cadherin present in IHC for DCIS?

yes

DCIS presentation

usually asymptomatic


- rarely a breast lump


- Pagget's Disease (unilateral)


--> red, scaly nipple

LCIS presentation

Asymptomatic


- incidental finding on breast specimen

Can LCIS be detected on mammography, if so how?

No

Can DCIS be detected on mammography, if so how?

yes


linear branching calcification

what is the cancer risk per year for LCIS and DCIS?

1% and accumalative

What cancer can LCIS progress into?

Lobular invasive


Ductal Invasive

What cancer can DCIS progress into?

Ductal Invasive


Other types

Treatment options for LCIS:

-careful followup --> screening (mammography)+ tamoxifin




- bi-lateral mastectomy (prophylactic)

Treatment options for DCIS:

-wide local excision


- radiotherapy

What can eczema be mistaken for in the breast?

Paggets Disease

Incidence of Invasive Lobular Breast Cancer?

20%

Incidence of Invasive Ductal Breast Cancer?

70-80%

The histology of Invasive Lobular BC?

- single file "indian file"


- discohesive


- encircle normal cells (targetoid)


- signet ring cells (cytoplasmic mucin vacuole)


- normal ducts visible within cancer lesion


- +- desmoplasia

The histology of Invasive Ductal BC?

- heterogenous


-tubules, cords, sheets, and nests


- cohesive


- strong desmoplastic response


- no normal ducts within cancer lesion

Is e- cadherin present in Invasive Lobular?

no



is e-caderin present in invasive ductal?

yes

receptors are in invasive lobular?

ER +ve


HER2 -ve

receptors in invasive ductal?

2/3 --> ER +ve, HER2 -ve




1/3 --> HER2 +ve

what are the clinical presentations of invasive breast carcinoma?

- breast lump/ pain

- nipple retraction/ discharge


- peux d'orange


- axillary lymph node involvement


- mets


- cachexia


- fatigue



signs of invasive BC in mammography?

densely "stellate" (hard)

possible met. location for invasive lobular?

- CSF


- Serosal surfacess


- GIT


- ovary


-uterus


- bone marrow



possible met. location for invasive ductal?

any site


- lung


-bone


- liver


- adrenal gland


- brain



possible treatment options for invasive BC?

-Surgery


+- chemotherapy


+- hormonal therapy (ER +ve)


+- radiotherapy (breast conservation surgery)


+- Herceptin (HER2 +ve)

genes involved in hereditary breast cancer?

BRCA1/2 (3% of BC)




tumour supressor/ DNA repair genes




p53 Li Fraumeni Syndrome

Diagnosing BC?

TRIPLE ASSESSMENT:




1. Histology and Clinical Examination




2. Imaging




3. Tissue Biopsy

There are 3 types of imaging


1. Mammography


2. Ultrasound


3. MRI




When is each test appropriate to use?

1. xray for elderly women




2. younger women




3. for those who have hereditary cancer

Major prognostic factors

- Invasive vs CIS


- Mets


- LN mets (worse with increase no.)


- Tumour size


- locally invasive


- inflammatory cancer - invaded dermal lymphatics



At which size, can a tumour be malignant?

< likely to become malignant if <1cm (mammograms can pick this up)




> likely to become malignant if between 2-3 cm (breast self-examination can detect this)

Minor prognostic markers:

- histological subtype (Ductal NOS worse)


- Histological grade: well, mod, poorly differentiated


- IHC (ER, PR)


- HER2/neu gene amplification


-lymph/vascular invasion


- proliferative rate


- DNA content


- gene expression profile

What is HER2/ neu?

HER2 protein is a transmembrane glycoprotein in the epidermal growth factor receptor family




-overexpressed in 20% of BC due to gene amplification

HER2/neu is associated with:

-poor outcome


- high nuclear grade


- poor response to hormonal therapy


- HER2 targeted therapy (Herceptin- Her2 monoclonal antibody)

Staging Breast cancer (AJCC):